✦ LIBER ✦

304 Capecitabine plus irinotecan (XELIRI) in first line metastatic colorectal cancer (MCRC): update on a phase II trial

✍ Scribed by Y.Z. Patt; J. Leibmann; D. Diamandidis; S.G. Eckhardt; M. Javie; G.R. Justice; W. Keiser; F.-C. Lee; W. Miller; E. Lin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

703 PUBLICATION Phase II multicenter stu

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

295 Capecitabine plus irinotecan (CAPIRI

✍ A. Grothey; K. Jordan; O. Kellner; C. Constantin; G. Dietrich; H. Kroening; L. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 326 KB

3068 POSTER Capecitabine + irinotecan +

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Results of a Phase II Trial of Cetuximab

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Oxaliplatin, irinotecan and capecitabine

✍ Zarate, R; Rodríguez, J; Bandres, E; Patiño-Garcia, A; Ponz-Sarvise, M; Viudez, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 352 KB

A Phase II Study of Capecitabine Plus Ox

✍ Makatsoris, Thomas ;Kalofonos, Haralabos P. ;Aravantinos, Gerasimos ;Papadimitri 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 93 KB